THE VACCINE CONGRESS STORY

 

 

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, at the 18th annual World Vaccine Congress, 3rd World Veterinary Vaccine Congress and 2nd Immune Profiling World Congress, we have content, networking and potential partners for you.

By bringing experts from the whole value chain under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

Take just three days out of the office to meet with 450+ potential customers who need to find solutions to challenges around the commercial and scientific issues in manufacturing, trials, strategy, regulation, veterinary, immune profiling, respiratory, therapeutic and emerging diseases vaccines.

 

Dr. Greg Poland explains why you should attend the World Vaccine Congress

 

SEE 2016 CONFERENCE AGENDA

 

World Vaccine Congress Europe Networking

World Vaccine Congress Europe Networking

World Vaccine Congress Europe Networking

 

 

NEW VACCINE TECHNOLOGY IS CHANGING
THE WHOLE INDUSTRY

 

BIOPROCESSING, DELIVERY AND MANUFACTURING

Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies

EMERGING AND RE-EMERGING DISEASES

Understand the opportunities for your business in reacting to global threats like malaria, dengue and Ebola

PRE-CLINICAL VALIDATION TO CLINICAL TRIALS

Assess how to improve your clinical trial performance, from developing novel immmunological assays to creating clinical efficacy

VETERINARY

From livestock to companion, gain crucial insights into the emerging infections and new technologies changing the landscape

THERAPEUTIC

From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast-evolving landscape whether you are interested in cancer and immunotherapy, allergy or chronic infectious diseases.

IMMUNE PROFILING

Discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and non-infectious diseases including cancer.

INFLUENZA AND RESPIRATORY

Find ways to improve development of universal influenza, RSV, MERS and Pneumococcal vaccines